Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non–ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)
2015 ◽
Vol 115
(10)
◽
pp. 1325-1332
◽
2013 ◽
Vol 61
(10)
◽
pp. E102
◽
2014 ◽
Vol 168
(6)
◽
pp. 869-877.e1
◽
2012 ◽
Vol 366
(1)
◽
pp. 20-33
◽
2003 ◽
Vol 146
(5)
◽
pp. 764-774
◽
2014 ◽
Vol 3
(3)
◽
pp. 246-256
◽
2004 ◽
Vol 3
(1)
◽
pp. 141
Keyword(s):
Keyword(s):